Haleon HLN.L · GBp
Consumer Staples · Personal Care Products · LSE · 🇬🇧 United Kingdom
FTSE 100
330.80p
-2.39%
Close of 9 Nov 2026, in pence
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Haleon
Its shares trade on LSE under the ticker HLN.L. It has been listed since 18 July 2022. It is a member of the FTSE 100. In the fiscal year to 31 December 2025, it reported revenue of £11.03bn and net income of £1.67bn. At that date it held total assets of £32.63bn and shareholders' equity of £16.43bn.
Haleon Plc engages in the provision of personal healthcare products. The company is headquartered in Brentford, Middlesex. The company went IPO on 2022-07-18. The Company’s product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The firm's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Personal Care Products
- Listed since
- 18 Jul 2022
- Employees
- 21,000
- Website
- haleon.com ↗
Leadership
Pay as last reported
- Sir Dave LewisIndependent Non-Executive Chairman of the Board£741,400
- Mr. Brian McnamaraChief Executive Officer, Executive Director, since 2022£9.1m
- Mrs. Dawn AllenChief Financial Officer, Executive Director, since 2024£2.4m
- Mr. Keith ChoyPresident, Asia Pacific
- Mr. Filippo LanziPresident, EMEA and LatAm
- Ms. Lisa PaleyPresident, North America
- Ms. Line De DeckerChief Human Resources Officer
- Ms. Tamara RogersChief Marketing Officer
- Mr. Adrian MorrisGeneral Counsel
- Mr. Carl HaneyChief Research & Development Officer
- Ms. Namrata PatelChief Supply Chain Officer
- Mr. Ed PetterChief Corporate Affairs Officer
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 72
- Environment
- 65
- Social
- 82
- Governance
- 68
- Direct emissions (scope 1)
- 68,000 t
- Energy emissions (scope 2)
- 124,000 t
- Value chain emissions (scope 3)
- 2,529,000 t
- Women in the workforce
- 46.54126%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Haleon's VMS brands include Centrum, Emergen-C, and Caltrate for vitamins and supplements.
- Haleon's respiratory brands include Otrivin, Theraflu, and Flonase for cold and flu relief.
- Haleon's oral health brands include Sensodyne, Polident, Parodontax, and Biotene for dental care.
Weaknesses
- Haleon's digestive health brands include TUMS, ENO, and Fenistil for stomach issues.
- Haleon's pain relief brands include Voltaren, Panadol, and Advil for pain management.
- Haleon's product portfolio spans North America, Europe, Middle East, Africa, and Latin America.
Opportunities
- Haleon's respiratory health solutions address cold, flu, nasal congestion, and allergies globally.
- Haleon's digestive health brands offer skin health and smoker's health solutions.
- Haleon's oral health brands target sensitive teeth and gum health in multiple markets.
Threats
- Haleon's VMS brands face competition in the vitamins and supplements market.
- Haleon's respiratory brands compete in the cold and flu relief segment.
- Haleon's pain relief brands face market saturation in pain management products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.